Paranasal sinus squamous cell carcinoma
MONDO:0044705A squamous cell carcinoma that arises from the mucosal epithelial surface of the ethmoid, frontal, maxillary, or sphenoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis.
Also known as: epidermoid carcinoma of paranasal sinus, epidermoid carcinoma of the paranasal sinus, paranasal sinus epidermoid carcinoma, paranasal sinus squamous cell carcinoma, squamous cell carcinoma of paranasal sinus, squamous cell carcinoma of the nasal cavity and sinuses, squamous cell carcinoma of the paranasal sinus, squamous cell carcinoma of the nasal cavity and paranasal sinuses
2863 clinical trials for this condition and its sub-types, 11 tagged with Paranasal sinus squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Paranasal sinus squamous cell carcinoma
-
Can a Three-Pronged attack shrink Hard-to-Treat head and neck cancers?
Disease control OngoingThis phase I trial is testing whether a combination of three treatments — an experimental drug called elimusertib, precise radiation therapy, and the immunotherapy pembrolizumab — can shrink or stabilize recurrent head and neck cancer that cannot be removed by surgery. The study …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug duo shows promise against tough head and neck cancers
Disease control OngoingThis study tests two drugs, pembrolizumab and cabozantinib, in 36 people with head and neck cancer that has returned or spread and cannot be surgically removed. The goal is to see if the combination shrinks tumors and delays cancer growth. Participants receive both drugs intraven…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC